Alto Neuroscience receives US patent for ALTO-207; strengthens IP portfolio for patients with treatment-resistant depression: Mountain View, California Saturday, January 17, 2026, ...

Everyone is encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1 ...

Phase 3 X-TOLE2 topline data for azetukalner in FOS expected March 2026 followed by anticipated NDA submission in H2 2026Five additional Phase 3 ...

Program will integrate existing neurocare clinics with HOPE Therapeutics clinics and will engage the already-installed base of 400+ Apollo® Transcranial Magnetic Stimulation (TMS) machines nationwide.

DENVER, CO / ACCESS Newswire / January 20, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central ...

Venezuela: Senate Republicans blocked a resolution that sought to force President Trump to seek congressional approval for ...

Conclusions This study suggests that a decrease in positive leadership behaviours has a hazardous effect on workers’ level of ...

The US stock market is shifting as President Trump reinforces his “America First” agenda through subsidies and incentives ...

DENVER, CO / ACCESS Newswire / January 20, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central n ...

Oregon’s huge investments in addiction treatment beds began to pay off in 2025, when hundreds of new beds came online. A 74-bed Portland residential treatment center opened in July in what used to be ...

Objective To assess prevalence and associated factors of adverse childhood experiences (ACEs) among patients with severe mood disorders (SMDs). Design An institution-based cross-sectional study.